Skip to content
Clinical Trials – home
Abnoba GmbH
Sponsor

Abnoba GmbH

Germany Allmendstrasse 55, Oeschelbronn, 75223, Germany

About the sponsor

The sponsor demonstrates a focused commitment to advancing integrative oncology through the development of complementary therapeutic approaches for cancer treatment. Their research portfolio encompasses investigations into biological cancer therapies that aim to support conventional oncological interventions. The organization's work reflects a dedication to exploring alternative pathways in cancer care, with particular emphasis on therapies derived from natural sources that may enhance patient outcomes and quality of life during cancer treatment.

  • Biological and Natural Product-Based Cancer Therapeutics
  • Supportive Care in Oncology
  • Complementary Medicine Integration

The research activities supported by this sponsor contribute to the expanding field of complementary and alternative medicine in oncology, addressing the growing clinical interest in holistic approaches to cancer management. Their investigations support the evidence base for integrative treatment strategies that combine conventional and complementary modalities.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Mitomycin
  • Sponsor:Abnoba GmbH

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).